Literature DB >> 6498777

Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension, and cell types. A study of 628 cases with Stage IB, IIA, and IIB cervical carcinoma.

T Inoue.   

Abstract

Depths of invasion by increments of 5 mm were evaluated as a prognostic factor in 628 patients after radical hysterectomy for Stage IB to IIB cervical carcinoma. Nodal metastases (N) were significantly increased when tumor invasion was deeper than 5, 10, and 30 mm. Parametrial extension (P) was significantly increased with 10-, 15-, and 25-mm invasion. In total, the corrected 5-year survival rates were significantly reduced with 20 and 30 mm invasion. However, survival rates were almost the same in N(-)P(-) cases, ranging from 96% to 100%. Reduction of the survival rates with 20-mm invasion was found in IIB, P(+), or N(-) cases, and with 30-mm invasion in IB, IIB, P(+), or N(+) cases. Subdivision by N or P factors revealed an evidence that in N(+) or P(+) cases, survival of patients with under 10-mm invasion was significantly poorer than that of cases with 10- to 15-mm invasion. These indicate that depth of invasion is a valuable prognostic factor in patients with nodal metastases or parametrial extension.

Entities:  

Mesh:

Year:  1984        PMID: 6498777     DOI: 10.1002/1097-0142(19841215)54:12<3035::aid-cncr2820541236>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Antitumor activity of a polysaccharide fraction from Laminaria japonica on U14 cervical carcinoma-bearing mice.

Authors:  Qingzhi Zhai; Xiuli Li; Yizhuo Yang; Ling Yu; Yuanqing Yao
Journal:  Tumour Biol       Date:  2013-08-08

3.  MRI-derived tumor thickness: an important predictor of outcome for T4a-staged tongue carcinoma.

Authors:  Wei-Lin Chen; Chin-Chuan Su; Chih-Ming Chen; Ming-Che Lee; Hui-Chuan Chen; Mu-Kuan Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-12       Impact factor: 2.503

4.  Perineural invasion in early-stage cervical cancer and its relevance following surgery.

Authors:  Yi Zhu; Guonan Zhang; Yan Yang; Ling Cui; Shijun Jia; Yu Shi; Shuiqin Song; Shiqiang Xu
Journal:  Oncol Lett       Date:  2018-02-26       Impact factor: 2.967

5.  Histological grading and DNA content as predictors of distant metastases in squamous cell carcinoma of the uterine cervix.

Authors:  M Anton; R Nenutil; J Zaloudík
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

6.  Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.

Authors:  Hiroyuki Yamazaki; Yukiharu Todo; Kazuhira Okamoto; Katsushige Yamashiro; Hidenori Kato
Journal:  J Gynecol Oncol       Date:  2015-07-14       Impact factor: 4.401

7.  Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.

Authors:  Bogdan Obrzut; Maciej Kusy; Andrzej Semczuk; Marzanna Obrzut; Jacek Kluska
Journal:  BMC Cancer       Date:  2017-12-12       Impact factor: 4.430

8.  Prediction of 10-year Overall Survival in Patients with Operable Cervical Cancer using a Probabilistic Neural Network.

Authors:  Bogdan Obrzut; Maciej Kusy; Andrzej Semczuk; Marzanna Obrzut; Jacek Kluska
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

9.  Risk strata-based therapy and outcome in stage Ib-IIa carcinoma cervix: single-centre ten-year experience.

Authors:  Rajshekar S Kundargi; B Guruprasad; Praveen Shankar Rathod; Pn Shakuntala; K Shobha; Vr Pallavi; K Uma Devi; Ud Bafna
Journal:  Ecancermedicalscience       Date:  2013-08-20

Review 10.  Magnetic resonance imaging of the cervix.

Authors:  Khashayar Rafat Zand; Caroline Reinhold; Hisashi Abe; Sharad Maheshwari; Ahmed Mohamed; Daniel Upegui
Journal:  Cancer Imaging       Date:  2007-05-28       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.